NeuroVasx

company

About

NeuroVasx is engaged in the development of technologies for the minimally-invasive treatment of hemorrhagic and ischemic strokes.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$8.50M
Industries
Health Care,Manufacturing,Medical
Founded date
Jan 1, 1997
Number Of Employee
1 - 10
Operating Status
Active

NeuroVasx is a medical device company engaged in the development and commercialization of technologies for the minimally-invasive treatment of hemorrhagic and ischemic strokes in the United States and internationally.

The company offers cPAX, a polymer strand delivered through a micro catheter for the minimally-invasive treatment of hemorrhagic and ischemic strokes as well as for the embolization of cerebral and intracranial aneurysms, abnormal bulges, and sacs in the wall of an artery in the brain. Its products are used to treat acute stroke and other cerebrovascular disorders.

NeuroVasx was founded in 1997 and is based in Maple Grove, Minnesota, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$8.50M
NeuroVasx has raised a total of $8.50M in funding over 2 rounds. Their latest funding was raised on Dec 10, 2007 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 10, 2007 Series Unknown $8.50M 1 Miller Johnson Steichen Kinnard Inc Detail

Investors

Number of Lead Investors
Number of Investors
1
1
NeuroVasx is funded by 1 investors. Miller Johnson Steichen Kinnard Inc are the most recent investors.
Investor Name Lead Investor Funding Round
Miller Johnson Steichen Kinnard Inc Yes Series Unknown